Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vioxx and Seroquel lawyers to act in consolidated Actos bladder cancer litigation

This article was originally published in Scrip

Executive Summary

It has come as no surprise that the US federal judge overseeing US product liability cases related to an alleged increased risk of bladder cancer with Takeda’s diabetes product Actos (pioglitazone) has named two plaintiffs’ lawyers with experience in some high-visibility pharmaceutical cases to lead the group. This includes mass tort experts involved with litigation surrounding Merck & Co's now withdrawn Vioxx (rofecoxib) and AstraZeneca's marketed schizophrenia and biopolar disorder drug Seroquel (quietapine fumurate).



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts